InfuSystem (NYSEAMERICAN:INFU) Upgraded to “Strong-Buy” at StockNews.com

StockNews.com upgraded shares of InfuSystem (NYSEAMERICAN:INFU) from a buy rating to a strong-buy rating in a report published on Tuesday morning.

InfuSystem Trading Down 4.8 %

Shares of InfuSystem stock opened at $7.56 on Tuesday. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.95 and a quick ratio of 1.54. InfuSystem has a 1-year low of $7.21 and a 1-year high of $11.44. The stock has a market cap of $160.73 million, a price-to-earnings ratio of 252.08 and a beta of 1.30.

Institutional Trading of InfuSystem

Large investors have recently made changes to their positions in the company. Heartland Advisors Inc. grew its stake in shares of InfuSystem by 17.6% in the 3rd quarter. Heartland Advisors Inc. now owns 500,000 shares of the medical instruments supplier’s stock valued at $4,820,000 after buying an additional 75,000 shares during the period. Citigroup Inc. grew its stake in shares of InfuSystem by 124.1% in the 3rd quarter. Citigroup Inc. now owns 50,640 shares of the medical instruments supplier’s stock valued at $488,000 after buying an additional 28,038 shares during the period. First Eagle Investment Management LLC grew its stake in shares of InfuSystem by 29.6% in the 3rd quarter. First Eagle Investment Management LLC now owns 468,400 shares of the medical instruments supplier’s stock valued at $4,515,000 after buying an additional 107,001 shares during the period. WINTON GROUP Ltd bought a new position in InfuSystem in the 3rd quarter valued at about $101,000. Finally, Wasatch Advisors LP lifted its position in InfuSystem by 3.4% in the 4th quarter. Wasatch Advisors LP now owns 846,609 shares of the medical instruments supplier’s stock valued at $8,923,000 after acquiring an additional 27,881 shares in the last quarter. 71.13% of the stock is currently owned by institutional investors and hedge funds.

InfuSystem Company Profile

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.